Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Multidisciplinary Return-to-work Rehabilitation and Return-to Work Follow-up

4. desember 2018 oppdatert av: Norwegian University of Science and Technology

Multidisciplinary Return-to-work Rehabilitation and Return-to-work Follow-up, a Randomized Study of Patients With Complex Symptom Disorders

The large number of people on long-term sick leave is a major public health concern in Norway. The main causes of disability are musculoskeletal and mental disorders. Long-term sick leave causes a decline in individual life-quality, is associated with increased risk for mental disorders and represents a very large cost for the Norwegian society.

The purpose of this study is to determine whether the patients included return to work after rehabilitation at Hysnes Rehabilitation Centre. This includes an investigation of what is considered to be the effect of Return-to-work rehabilitation measured before, during and after the stay at the rehabilitation centre:

The study specifically looks at the effect of structured and standardized return-to-work follow up of the patient, including contact with stakeholders (general practitioner, social security office and workplace).

In addition there is a need to describe the patients participating in the program. The aetiology of complex symptom disorders is poorly understood and the role of genetics and stress is not translatable to a complex symptom population. This complicates the transition from current biological research to a clinical use regarding these patients. If the investigators can assist in understanding how these patients, who are multiusers of health care and have received sickness benefit for a long time, develop their disorders and symptoms, it will be of great importance to the Norwegian community. Therefore the study consists of multimodal measurements of the patients before, during and after a rehabilitation programme at Hysnes Rehabilitation Centre. These measures include genotype, saliva cortisol, medical-, psychological-, physiological diagnostics and work related factors.

Related aims:

Investigate if multidisciplinary treatment based on acceptance and commitment therapy, contributes to normalisation of cortisol release with regards to a standardized stress test.

See wether individual differences regarding the stress profile can predict return to work in patients with complex symptom disorders.

Investigate genetic risk factors in relation to Return to Work rehabilitation and identify treatment moderators in a multidisciplinary rehabilitation program.

Studieoversikt

Studietype

Intervensjonell

Registrering (Faktiske)

214

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Trondheim, Norge
        • Hysnes Helsefort, St Olavs Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 59 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion criteria:

  • Age between 18-59 years
  • A self defined goal of increasing their work ability and work participation within a period of no more than six months
  • They fill the criteria of a complex symptom disorder, or they are diagnosed with a common mental disorder
  • A satisfactory level of examination and treatment to participate at Hysnes Rehabilitation Centre
  • Sick leave > 8weeks or receiving work ability assessment benefit for any diagnosis, except as stated below.
  • On a level of linguistic, physical and mental function required to participate in the rehabilitation

Exclusion criteria:

  • Ongoing alcohol/drug abuse
  • Ongoing psychosis, ongoing manic episode or suicide risk
  • Pregnancy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Return to work follow-up
Regular contact between the patient and his/her caretaker at the rehabilitation center over a 6 month period, including joint communication between patient, caretaker at the rehabilitation center and stake holders such as social security office, general practitioner and workplace.
3 1/2 weeks of Return-to-work rehabilitation followed by 6 months of Return-to-work follow-up
Andre navn:
  • Acceptance commitment therapy
Aktiv komparator: Standard follow-up
Standard follow-up of the patient after ended rehabilitation by the return-to-work stakeholders, ie. the general practitioner, social security office and the employer. Limited contact between the caretaker at the rehabilitation center and the patient and stakeholders.
3 1/2 weeks of Return-to-work rehabilitation followed by standard follow-up
Andre navn:
  • Acceptance commitment therapy

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Return to work
Tidsramme: 1 year after the end of the stay at the rehabilitation center.
Differences in cumulative days of sick leave, as reported by the government database "FD-Trygd".
1 year after the end of the stay at the rehabilitation center.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
quality of life
Tidsramme: 5 years after the end of the rehabilitation stay
Quality of life is assessed by 15D, SF8 and function subscale in SF-36
5 years after the end of the rehabilitation stay
Functional status
Tidsramme: 5 year after the end of the rehabilitation stay
Functional status will be measured with elements from the Norwegian Function Assessment Scale (Osteras et al., 2007) and the function subscale of SF-36 (Ware Jr & Sherbourne, 1992)
5 year after the end of the rehabilitation stay
level of symptoms (somatic and psychological)
Tidsramme: 5 year after the end of the rehabilitation stay,

The Hospital Anxiety and Depression Scale (HADS) measure changes in anxiety and depression.

Changes regarding physical and mental fatigue are registered through the Chalder Fatigue Questionnaire.

Changes in participants subjective experience of pain measured by numerical rating scale (NRS)

5 year after the end of the rehabilitation stay,

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Petter Borchgrevink, Norwegian University of Science and Technology

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. januar 2012

Primær fullføring (Faktiske)

1. juni 2014

Studiet fullført (Faktiske)

1. september 2018

Datoer for studieregistrering

Først innsendt

8. mars 2012

Først innsendt som oppfylte QC-kriteriene

29. mars 2012

Først lagt ut (Anslag)

2. april 2012

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. desember 2018

Siste oppdatering sendt inn som oppfylte QC-kriteriene

4. desember 2018

Sist bekreftet

1. desember 2018

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2010/2404

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere